[1] Metersky ML,Wang Y,Klompas M,et al. Trend in ventilator-associated pneumonia rates between 2005 and 2013[J]. JAMA, 2016,316(22):2427-2429. [2] Magill SS,Hellinger W,Cohen J,et al. Prevalence of healthcare-associated infections in acute care hospitals in Jacksonville, Florida[J]. Infect Cont Hosp Ep, 2012,33(3):283-291. [3] Flanders SA, Collard HR, Saint S. Nosocomial pneumonia: state of the science[J]. Am J Infect Control, 2006,34(2):84-93. [4] Melsen WG,Rovers MM,Groenwold RH,et al. Attributable mortality of ventilator-associated pneumonia: a meta-analysis of individual patient data from randomised prevention studies[J]. Lancet Infect Dis, 2013,13(8):665-671. [5] Micek ST,Chew B,Hampton N,et al. A case-control study assessing the impact of nonventilated hospital-acquired pneumonia on patient outcomes[J]. Chest, 2016,150(5):1008-1014. [6] 中华医学会呼吸病学分会感染学组. 中国成人医院获得性肺炎与呼吸机相关性肺炎诊断和治疗指南(2018年版)[J]. 中华结核和呼吸杂志, 2018,4(41):255-280. [7] Ozgur ES,Horasan ES,Karaca K,et al. Ventilator-associated pneumonia due to extensive drug-resistant Acinetobacter baumannii: risk factors, clinical features, and outcomes[J]. Am J Infect Control, 2014,42(2):206-208. [8] Nanao T, Nishizawa H, Fujimoto J, et al. Additional medical costs associated with ventilator-associated pneumonia in an intensive care unit in Japan[J]. Am J Infect Control, 2021,49(3):340-344. [9] 许娜娜, 王昊, 周敏. 泛耐药鲍曼不动杆菌呼吸机相关性肺炎的归因住院时长与住院费用研究[J]. 中国消毒学杂志, 2020,37(4):293-296. [10] Kollef MH,Hamilton CW,Ernst FR. Economic impact of ventilator-associated pneumonia in a large matched cohort[J]. Infect Contr Hosp Ep, 2012,33(3):250-256. [11] Wang Y, Zhang R, Liu W. Distribution and drug resistance of pathogenic bacteria in ventilator-associated pneumonia at a local hospital of North-eastern China[J]. Infect Drug Resist, 2018,11:2249-2255. [12] 田晓玲, 孙吉花, 王玉果, 等. 某三级综合医院神经外科医院获得性感染经济损失评价[J]. 滨州医学院学报, 2017,40(1):56-58. [13] Cakir EE,Hatipoglu ON,Yilmam I,et al. Economic burden of nosocomial pneumonia in non-intensive care clinics[J]. Tuberk Toraks, 2015,63(1):8-12. [14] 范蓓蓉, 周慧君, 陈培服, 等. ICU机械通气患者发生呼吸机相关性肺炎的影响因素与预后分析[J]. 中华医院感染学杂志, 2019,29(4):519-522. [15] 陈洪英, 李爱琴, 王晓琼, 等. 重症监护病房重症患者呼吸机相关肺炎的病原菌特点及来源的研究[J]. 中国消毒学杂志, 2020,37(10):730-732. [16] 刘东欣,江琴. ICU老年患者呼吸机相关性肺炎合并多重耐药菌感染病原菌分布及危险因素[J]. 实用预防医学,2022,29(11):1381-1384. [17] Speck K, Rawat N, Weiner NC, et al. A systematic approach for developing a ventilator-associated pneumonia prevention bundle[J]. Am J Infect Control, 2016,44(6):652-656. [18] Luckraz H,Manga N,Senanayake EL,et al. Cost of treating ventilator-associated pneumonia post cardiac surgery in the National Health Service: results from a propensity-matched cohort study[J]. J Intensive Care Soc, 2018,19(2):94-100.
2024, Vol. 31 
